Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Carcinogenicity

Currently viewing:

Administrative data

Description of key information

Due to the scarced data about carcinogenicity the substance is considered inconclusive 

Key value for chemical safety assessment

Carcinogenicity: via inhalation route

Link to relevant study records
Reference
Endpoint:
carcinogenicity: inhalation
Type of information:
experimental study
Adequacy of study:
weight of evidence
Study period:
2012
Reliability:
2 (reliable with restrictions)
Rationale for reliability incl. deficiencies:
other: see 'Remark'
Remarks:
A reliable secondary source, summarising 2-mercaptobenzimidazole properties, was used. However the primary sources were not revisited in order to verify their contents; for this reason reliability score 2 was used. The used secondary source has been updated on 2012; therefore it covers the most updated literature on the substance.
Qualifier:
no guideline available
Principles of method if other than guideline:
It is not specified
GLP compliance:
not specified
Species:
rat
Strain:
Fischer 344
Sex:
not specified
Route of administration:
inhalation
Type of inhalation exposure (if applicable):
not specified
Vehicle:
not specified
Relevance of carcinogenic effects / potential:
The administered dose shows a thyroid hyperplasia. Thyroid follicular cell hyperplasia
Dose descriptor:
dose level:
Effect level:
ca. 6.2 mg/kg bw/day
Based on:
test mat.
Sex:
male/female
Basis for effect level:
other: Increased thyroid weight and thyroid follicular cell hyperplasia
Remarks on result:
other: Effect type: carcinogenicity (migrated information)
Dose descriptor:
other:
Effect level:
ca. 3.1 mg/kg bw/day
Based on:
test mat.
Sex:
not specified
Basis for effect level:
other: Thyroid follicular cell hyperplasia was also seen in rats at 3.1 mg/m3
Remarks on result:
other: Effect type: carcinogenicity (migrated information)
Conclusions:
Due to the scarced data about carcinogenicity the substance is considered inconclusive according to Directive 67/548/EEC and to Regulation (EC) n. 1272/2008.
Endpoint conclusion
Endpoint conclusion:
adverse effect observed
Study duration:
chronic
Species:
rat

Justification for classification or non-classification

Due to the scarced data about carcinogenicity the substance is considered inconclusive according to Directive 67/548/EEC and to Regulation (EC) n. 1272/2008.

Additional information

Due to the scarced data about carcinogenicity the substance is considered inconclusive according to Directive 67/548/EEC and to Regulation (EC) n. 1272/2008.


Justification for selection of carcinogenicity via inhalation route endpoint:
This study is preferred for the level dose described.

Carcinogenicity: via inhalation route (target organ): glandular: thyroids